PATENT CLAIM ANALYSIS

Application Number: 16241410
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-09
Patent Classification: ["424", "161100"]

Abstract:
The present invention discloses products and the methods of uses of the products for preventing and treating infectious diseases and the disorders or conditions inducible by harmful antibodies. The harmful antibodies are induced during infection, or vaccination, or use of therapeutic antibodies. The products of the present disclosure comprise immunoglobulin products, serum or plasma, specific antibodies to viral pathogens.

Claim (Index 3):
The therapeutic product of  claim 1 , wherein the serious adverse reaction is Guillain-Barre syndrome-like condition, death, abortion, immature or delayed delivery, fetal death, or neonatal death.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 99.0
- Lexical Diversity: 1.65
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14775984', '14623956', '13577419', '15811486', '14516197']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7389457318266229
- 35 USC 102 Novelty (BERT): 0.5189679689668288
- Combined Prediction Score: 0.7169479555406436
- Mean Citation Score: 184.018912
- Max Citation Score: 206.98625
- Similarity Product: 108.54978197708726

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test